244 related articles for article (PubMed ID: 32187077)
1. Human Umbilical Cord-Derived Mesenchymal Stem Cells for Acute Respiratory Distress Syndrome.
Yip HK; Fang WF; Li YC; Lee FY; Lee CH; Pei SN; Ma MC; Chen KH; Sung PH; Lee MS
Crit Care Med; 2020 May; 48(5):e391-e399. PubMed ID: 32187077
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.
Wilson JG; Liu KD; Zhuo H; Caballero L; McMillan M; Fang X; Cosgrove K; Vojnik R; Calfee CS; Lee JW; Rogers AJ; Levitt J; Wiener-Kronish J; Bajwa EK; Leavitt A; McKenna D; Thompson BT; Matthay MA
Lancet Respir Med; 2015 Jan; 3(1):24-32. PubMed ID: 25529339
[TBL] [Abstract][Full Text] [Related]
4. Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial.
Lanzoni G; Linetsky E; Correa D; Messinger Cayetano S; Alvarez RA; Kouroupis D; Alvarez Gil A; Poggioli R; Ruiz P; Marttos AC; Hirani K; Bell CA; Kusack H; Rafkin L; Baidal D; Pastewski A; Gawri K; Leñero C; Mantero AMA; Metalonis SW; Wang X; Roque L; Masters B; Kenyon NS; Ginzburg E; Xu X; Tan J; Caplan AI; Glassberg MK; Alejandro R; Ricordi C
Stem Cells Transl Med; 2021 May; 10(5):660-673. PubMed ID: 33400390
[TBL] [Abstract][Full Text] [Related]
5. Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study.
Zheng G; Huang L; Tong H; Shu Q; Hu Y; Ge M; Deng K; Zhang L; Zou B; Cheng B; Xu J
Respir Res; 2014 Apr; 15(1):39. PubMed ID: 24708472
[TBL] [Abstract][Full Text] [Related]
6. Cryopreserved, Xeno-Free Human Umbilical Cord Mesenchymal Stromal Cells Reduce Lung Injury Severity and Bacterial Burden in Rodent Escherichia coli-Induced Acute Respiratory Distress Syndrome.
Curley GF; Jerkic M; Dixon S; Hogan G; Masterson C; O'Toole D; Devaney J; Laffey JG
Crit Care Med; 2017 Feb; 45(2):e202-e212. PubMed ID: 27861182
[TBL] [Abstract][Full Text] [Related]
7. Feasibility Study of Cord Tissue Derived Mesenchymal Stromal Cells in COVID-19-Related Acute Respiratory Distress Syndrome.
Shaz BH; Kraft BD; Troy JD; Poehlein E; Chen L; Cheatham L; Manyara R; Hanafy K; Brown L; Scott M; Palumbo R; Vrionis F; Kurtzberg J
Stem Cells Transl Med; 2023 Apr; 12(4):185-193. PubMed ID: 36929827
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
[TBL] [Abstract][Full Text] [Related]
9. Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial.
Matthay MA; Calfee CS; Zhuo H; Thompson BT; Wilson JG; Levitt JE; Rogers AJ; Gotts JE; Wiener-Kronish JP; Bajwa EK; Donahoe MP; McVerry BJ; Ortiz LA; Exline M; Christman JW; Abbott J; Delucchi KL; Caballero L; McMillan M; McKenna DH; Liu KD
Lancet Respir Med; 2019 Feb; 7(2):154-162. PubMed ID: 30455077
[TBL] [Abstract][Full Text] [Related]
10. Umbilical cord-derived mesenchymal stem (stromal) cells for treatment of severe sepsis: aphase 1 clinical trial.
He X; Ai S; Guo W; Yang Y; Wang Z; Jiang D; Xu X
Transl Res; 2018 Sep; 199():52-61. PubMed ID: 30044959
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Mesenchymal Stem Cell Therapy for COVID-19-Induced ARDS Patients: A Case Report.
Kim K; Bae KS; Kim HS; Lee WY
Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556900
[No Abstract] [Full Text] [Related]
12. Specific Clinical and Immunological Changes Following Mesenchymal Stem Cell Transplantation in COVID-19-induced Acute Respiratory Distress Syndrome Patients: A Phase-I Clinical Trial.
Kaffash Farkhad N; Sedaghat A; Reihani H; Adhami Moghadam A; Bagheri Moghadam A; Khadem Ghaebi N; Khodadoust MA; Nikpoor AR; Tavakol Afshari J
Iran J Allergy Asthma Immunol; 2022 Dec; 21(6):687-703. PubMed ID: 36640060
[TBL] [Abstract][Full Text] [Related]
13. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease.
Weiss ML; Medicetty S; Bledsoe AR; Rachakatla RS; Choi M; Merchav S; Luo Y; Rao MS; Velagaleti G; Troyer D
Stem Cells; 2006 Mar; 24(3):781-92. PubMed ID: 16223852
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Acute Respiratory Distress Syndrome Caused by COVID-19 with Human Umbilical Cord Mesenchymal Stem Cells.
Bukreieva T; Svitina H; Nikulina V; Vega A; Chybisov O; Shablii I; Ustymenko A; Nemtinov P; Lobyntseva G; Skrypkina I; Shablii V
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901868
[TBL] [Abstract][Full Text] [Related]
15. Intratracheal administration of umbilical cord blood-derived mesenchymal stem cells in a patient with acute respiratory distress syndrome.
Chang Y; Park SH; Huh JW; Lim CM; Koh Y; Hong SB
J Korean Med Sci; 2014 Mar; 29(3):438-40. PubMed ID: 24616596
[TBL] [Abstract][Full Text] [Related]
16. Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessment.
Aghayan HR; Salimian F; Abedini A; Fattah Ghazi S; Yunesian M; Alavi-Moghadam S; Makarem J; Majidzadeh-A K; Hatamkhani A; Moghri M; Danesh A; Haddad-Marandi MR; Sanati H; Abbasvandi F; Arjmand B; Azimi P; Ghavamzadeh A; Sarrami-Forooshani R
Stem Cell Res Ther; 2022 Jul; 13(1):365. PubMed ID: 35902979
[TBL] [Abstract][Full Text] [Related]
17. Effects of Mesenchymal Stem Cell Treatment on Systemic Cytokine Levels in a Phase 1 Dose Escalation Safety Trial of Septic Shock Patients.
Schlosser K; Wang JP; Dos Santos C; Walley KR; Marshall J; Fergusson DA; Winston BW; Granton J; Watpool I; Stewart DJ; McIntyre LA; Mei SHJ;
Crit Care Med; 2019 Jul; 47(7):918-925. PubMed ID: 30720538
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a prospective, single arm, phase I trial.
Chen Y; Xu Y; Chi Y; Sun T; Gao Y; Dou X; Han Z; Xue F; Li H; Liu W; Liu X; Dong H; Fu R; Ju M; Dai X; Wang W; Ma Y; Song Z; Gu J; Gong W; Yang R; Zhang L
Signal Transduct Target Ther; 2024 Apr; 9(1):102. PubMed ID: 38653983
[TBL] [Abstract][Full Text] [Related]
19. Umbilical Cord-derived Mesenchymal Stem Cells with Surfactant Protein B Alleviates Inflammatory Response in Acute Respiratory Distress Syndrome by Regulating Macrophage Polarization.
Xu H; Nie G; Yin T; Shao C; Ding D; Zou M
Balkan Med J; 2022 Mar; 39(1):130-139. PubMed ID: 35330560
[TBL] [Abstract][Full Text] [Related]
20. Treatment of COVID-19-associated ARDS with umbilical cord-derived mesenchymal stromal cells in the STROMA-CoV-2 multicenter randomized double-blind trial: long-term safety, respiratory function, and quality of life.
Sitbon A; Hauw-Berlemont C; Mebarki M; Heming N; Mayaux J; Diehl JL; Demoule A; Annane D; Marois C; Demeret S; Weiss E; Voiriot G; Fartoukh M; Constantin JM; Mégarbane B; Plantefève G; Boucher-Pillet H; Churlaud G; Cras A; Maheux C; Pezzana C; Diallo MH; Lebbah S; Ropers J; Salem JE; Straus C; Menasché P; Larghero J; Monsel A;
Stem Cell Res Ther; 2024 Apr; 15(1):109. PubMed ID: 38637891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
